Doubek M - Search Results

1

Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.

Panovská A, Žák P, Jurková T, Arpáš T, Brychtová Y, Vašíková A, Hrabčáková V, Prchlíková A, Filipová M, Doubek M. Panovská A, et al. Among authors: doubek m. Hematol Oncol. 2024 May;42(3):e3280. doi: 10.1002/hon.3280. Hematol Oncol. 2024. PMID: 38741354

2

[Lymphocytosis with large granular lymphocytes: case report].

Brychtová Y, Doubek M, Mayer J, Bulíková A, Krahulová M. Brychtová Y, et al. Among authors: doubek m. Vnitr Lek. 2000 May;46(5):301-4. Vnitr Lek. 2000. PMID: 11227187 Czech.

3

[Treatment of acute lymphoblastic leukemia in adults with seven-drug induction therapy and intensive consolidation with or without autologous stem cell transplantation followed by maintenance therapy. Experience of a single center].

Doubek M, Mayer J, Korístek Z, Protivánková M, Brychtová Y, Oborilová A, Král Z, Klabusay M, Tomíska M, Buchtová I, Vorlícek J. Doubek M, et al. Cas Lek Cesk. 2002 Mar 1;141(4):122-6. Cas Lek Cesk. 2002. PMID: 12046256 Czech.

4

Pulse cyclophosphamide for corticosteroid-refractory graft-versus-host disease.

Mayer J, Krejcí M, Doubek M, Pospísil Z, Brychtová Y, Tomíska M, Rácil Z. Mayer J, et al. Among authors: doubek m. Bone Marrow Transplant. 2005 Apr;35(7):699-705. doi: 10.1038/sj.bmt.1704829. Bone Marrow Transplant. 2005. PMID: 15696180

5

Idiopathic systemic capillary leak syndrome misdiagnosed and treated as polycythemia vera.

Doubek M, Brychtova Y, Tomiska M, Mayer J. Doubek M, et al. Acta Haematol. 2005;113(2):150-1. doi: 10.1159/000083455. Acta Haematol. 2005. PMID: 15802896 No abstract available.

6

Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease.

Krejci M, Doubek M, Buchler T, Brychtova Y, Vorlicek J, Mayer J. Krejci M, et al. Among authors: doubek m. Ann Hematol. 2005 Oct;84(10):681-5. doi: 10.1007/s00277-005-1070-0. Epub 2005 Jul 7. Ann Hematol. 2005. PMID: 16001244

7

Acute myeloid leukemia treatment in patients over 60 years of age. Comparison of symptomatic, palliative, and aggressive therapy.

Doubek M, Palasek I, Brychtova Y, Buchtova I, Mayer J. Doubek M, et al. Neoplasma. 2005;52(5):411-4. Neoplasma. 2005. PMID: 16151586

8

Analysis of risk factors: the rationale of the guidelines of the Czech Hematological Society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia.

Schwarz J, Pytlík R, Doubek M, Brychtová Y, Dulícek P, Campr V, Kren L, Penka M. Schwarz J, et al. Among authors: doubek m. Semin Thromb Hemost. 2006 Apr;32(3):231-45. doi: 10.1055/s-2006-939434. Semin Thromb Hemost. 2006. PMID: 16673277

9

Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemia.

Krejci M, Mayer J, Doubek M, Brychtova Y, Pospisil Z, Racil Z, Dvorakova D, Lengerova M, Horky O, Koristek Z, Dolezal T, Vorlicek J. Krejci M, et al. Among authors: doubek m. Bone Marrow Transplant. 2006 Oct;38(7):483-91. doi: 10.1038/sj.bmt.1705478. Epub 2006 Aug 28. Bone Marrow Transplant. 2006. PMID: 16980996

10

[Density expression of the CD20 antigen on population of tumor cells in patients with chronic B-lymphocyte lymphoproliferative diseases].

Suková V, Klabusay M, Coupek P, Brychtová Y, Doubek M, Mayer J. Suková V, et al. Among authors: doubek m. Cas Lek Cesk. 2006;145(9):712-6; discussion 716-7. Cas Lek Cesk. 2006. PMID: 17091727 Czech.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters